Obeticholic acid for the Amelioration of Cognitive Symptoms trial -1 (OACS-1)
Latest Information Update: 17 Sep 2024
At a glance
- Drugs Obeticholic acid (Primary)
- Indications Cognition disorders; Primary biliary cirrhosis
- Focus Therapeutic Use
- Acronyms OACS-1
- 23 Aug 2024 Planned End Date changed from 28 Feb 2025 to 25 Apr 2025.
- 23 Feb 2024 Planned End Date changed from 30 Sep 2024 to 28 Feb 2025.
- 16 Aug 2023 Status changed to recruiting.